ArticleVeterinary and animal science2026
New frontiers in regenerative medicine: Protocol standardization and morphological assessment of leukocyte-platelet rich fibrin in cows, with a longitudinal study on growth factor release dynamics.
Article in Veterinary and animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multivariate Temporal Inflammatory-Regenerative Signatures of Bovine Platelet-Rich Gel Supernatants Under Different Storage Temperatures.Gels (Basel, Switzerland) · 2026Article
- Exploratory Multivariate Analysis of Mediator Organization in Canine Platelet-Rich Gel Under NSAID Exposure.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukocyte-Platelets Rich Fibrin (L-PRF) is a platelet-derived autologous agent. It is a powerful wound-sealing biological scaffold that promotes the healing process through the release of growth factors (GFs) and matrix proteins. To date, the l-PRF in bovines has not yet been investigated and a standardized production protocol has not yet been described. Therefore, the aim of the study was to standardise the l-PRF production protocol and to evaluate macroscopically and histologically the l-PRF membranes obtained and observe the GFs release over time and lactation phases: at 1 h (T0), 4 h (T1), 24 h (T2), and 168 h (T3) after extraction. Eighty cows were divided into four groups of 20 animals, based on their lactation phase. A whole blood sample of 20 ml was taken and divided for l-PRF clot production and haemato-biochemical investigations. The membranes presented the following overall mean characteristics: a length of 34.4 ± 7.3 cm, a width of 12.5 ± 2.6 cm, and a weight of 4.9 ± 0.17 cm. Histological analysis showed a well-defined histoarchitecture consisting of a first layer of erythrocytes, a layer of leukocytes, erythrocytes, and platelets, a layer of leukocytes, a layer of platelets, and finally a layer of slightly eosinophilic fibrin. The GFs significantly increased with upward trends in all phases of lactation and at each time control, overlapping the behavior of GF in other species. Based on the encouraging findings of this study, further clinical trials for applicative potential of the l-PRF membrane in bovine medicine should be assessed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.